Impact of Generics on the Biotechnology Industry

Joe McCracken, Genentech

Loading video...

Joe comments on the widely held debate in the biotechnology industry about the legality and effectiveness of generic drugs. Joe feels that as long as the follow-on biologics are effective and safe, they would be great for the industry. He states the Genentech will compete by continually innovating better drugs.

Nov 30, 2006

More from this event

More on this topic